<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Germ, Julija</dc:creator>
  <dc:creator>Poirel, Laurent</dc:creator>
  <dc:creator>Cerar Kisek, Tjasa</dc:creator>
  <dc:creator>Cvitkovic Spik, Vesna</dc:creator>
  <dc:creator>Katja Seme</dc:creator>
  <dc:creator>Mueller Premru, Manica</dc:creator>
  <dc:creator>Lejko Zupanc, Tatjana</dc:creator>
  <dc:creator>Nordmann, Patrice</dc:creator>
  <dc:creator>Pirs, Mateja</dc:creator>
  <dc:date>2019-11-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Acinetobacter baumannii primarily causes colonization, yet it can be an opportunistic  pathogen associated with hospital-acquired infections. Many countries report rapid  spread of carbapenem-resistant Acinetobacter baumannii (CRAb) which limits  treatment options, with colistin frequently being the last line treatment option. The aim  of our study was to evaluate a recently developed rapid method, namely the Rapid  ResaPolymyxin test, for detection of colistin resistance (ColR) in Acinetobacter  baumannii. This test was used for rapid screening of colistin resistance in a clinical  setting where there is endemicity of CRAb isolates. A total of 82 A. baumannii clinical  isolates were included in the evaluation. The majority of them were resistant to  carbapenems (75/82, 91.5%). A total of 37 isolates (45.1%) were resistant to colistin,  all being resistant to carbapenems. None of the ColR isolates carried the plasmid- mediated mcr-1 to -5 genes. The Rapid ResaPolymyxin NP test reached a 95.1%  categorical agreement with results of reference broth microdilution method, with  93.3% sensitivity and specificity, and positive and negative predictive values being  respectively at 92.3% and 97.7%. The Rapid ResaPolymyxin NP test performed well  on our collection of clinical and surveillance CRAb isolates from the Central Slovenia  region. The test is inexpensive and easy to integrate into laboratory workflow. The  main value of the test is rapid categorization of susceptibility and resistance which has  important implications with respect to the treatment strategy as well as the infection  control measures.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308396</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308396/files/nor_erb.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s10096-019-03657-1</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>European Journal of Clinical Microbiology &amp; Infectious Diseases. - 2019, vol. 38, no. 11, p. 2159–2162</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
